Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

665 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients.
Meredith IT, Dumonteil N, Blackman DJ, Tchétché D, Walters DL, Hildick-Smith D, Manoharan G, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Modine T, Van Mieghem NM, Feldman T, Allocco DJ, Dawkins KD. Meredith IT, et al. Among authors: feldman t. EuroIntervention. 2017 Sep 20;13(7):788-795. doi: 10.4244/EIJ-D-16-01024. EuroIntervention. 2017. PMID: 28555592 Free article.
1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD. Meredith IT, et al. Among authors: feldman te. JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-384. doi: 10.1016/j.jcin.2015.10.024. JACC Cardiovasc Interv. 2016. PMID: 26892084 Free article. Clinical Trial.
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.
Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchétché D, Rovin JD, Buchbinder M, Meredith IT, Götberg M, Bjursten H, Meduri C, Salinger MH, Allocco DJ, Dawkins KD. Feldman TE, et al. JAMA. 2018 Jan 2;319(1):27-37. doi: 10.1001/jama.2017.19132. JAMA. 2018. PMID: 29297076 Free PMC article. Clinical Trial.
Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial.
Asch FM, Vannan MA, Singh S, Khandheria B, Little SH, Allocco DJ, Meredith IT, Feldman TE, Reardon MJ, Weissman NJ. Asch FM, et al. Among authors: feldman te. Circulation. 2018 Jun 12;137(24):2557-2567. doi: 10.1161/CIRCULATIONAHA.118.034129. Epub 2018 Mar 12. Circulation. 2018. PMID: 29530883 Clinical Trial.
Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial.
Reardon MJ, Feldman TE, Meduri CU, Makkar RR, O'Hair D, Linke A, Kereiakes DJ, Waksman R, Babliaros V, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchétché D, Rovin JD, Lhermusier T, Carrié D, Hodson RW, Allocco DJ, Meredith IT; Reprise III Investigators. Reardon MJ, et al. Among authors: feldman te. JAMA Cardiol. 2019 Mar 1;4(3):223-229. doi: 10.1001/jamacardio.2019.0091. JAMA Cardiol. 2019. PMID: 30810703 Free PMC article. Clinical Trial.
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial.
Meduri CU, Kereiakes DJ, Rajagopal V, Makkar RR, O'Hair D, Linke A, Waksman R, Babliaros V, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Schindler J, Allocco DJ, Meredith IT, Feldman TE, Reardon MJ. Meduri CU, et al. Among authors: feldman te. J Am Heart Assoc. 2019 Nov 5;8(21):e012594. doi: 10.1161/JAHA.119.012594. Epub 2019 Oct 23. J Am Heart Assoc. 2019. PMID: 31640455 Free PMC article. Clinical Trial.
Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study.
Lim DS, Kar S, Spargias K, Kipperman RM, O'Neill WW, Ng MKC, Fam NP, Walters DL, Webb JG, Smith RL, Rinaldi MJ, Latib A, Cohen GN, Schäfer U, Marcoff L, Vandrangi P, Verta P, Feldman TE. Lim DS, et al. JACC Cardiovasc Interv. 2019 Jul 22;12(14):1369-1378. doi: 10.1016/j.jcin.2019.04.034. Epub 2019 Jun 26. JACC Cardiovasc Interv. 2019. PMID: 31255562 Free article.
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?
Roy AK, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys PA, Dawkins KD, Kappetein AP, Mohr FW, Colombo A, Feldman T, Morice MC. Roy AK, et al. Among authors: feldman t. EuroIntervention. 2017 Sep 20;13(7):828-834. doi: 10.4244/EIJ-D-16-00991. EuroIntervention. 2017. PMID: 28320685 Free article. Clinical Trial.
The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR.
Bjursten H, Nozohoor S, Johansson M, Zindovic I, Appel CF, Sjögren J, Dencker M, Olivecrona G, Harnek J, Koul S, Feldman T, Reardon MJ, Götberg M. Bjursten H, et al. Among authors: feldman t. BMC Cardiovasc Disord. 2017 Jan 13;17(1):25. doi: 10.1186/s12872-016-0466-1. BMC Cardiovasc Disord. 2017. PMID: 28086805 Free PMC article.
665 results